Tevogen Logo Notified.png
Tevogen CEO Expresses Gratitude for Unprecedented Public Support of Company’s Business Model of Commercial Success Through Patient Accessibility and Reaffirms His Commitment to Share Additional Details in the Coming Days
October 18, 2024 22:46 ET | Tevogen Bio Inc
WARREN, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN) is a clinical-stage specialty immunotherapy biotech developing off-the-shelf,...
RZ_Logo.png
Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024
October 18, 2024 09:00 ET | Roadzen Inc.
Roadzen to Present at the ThinkEquity Investor Conference October 30, 2024
Logo.png
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
October 18, 2024 08:00 ET | Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc. to Present at the 2024 ThinkEquity Conference
OMH.png
Ohmyhome to Announce Q3 2024 Growth Updates
October 18, 2024 05:00 ET | Ohmyhome Pte. Ltd.
Singapore, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Ohmyhome Ltd. (NASDAQ: OMH, “Ohmyhome”), a one-stop-shop property technology platform providing end-to-end property solutions and services including...
image1.png
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Acadia Healthcare Company, Inc.
October 16, 2024 21:20 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Acadia Healthcare To Contact Him Directly To Discuss Their...
logo-horizontal-main.png
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
October 16, 2024 16:15 ET | OncoCyte Corporation
Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles
Optinose_logo_RGB.png
Optinose Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 16, 2024 16:05 ET | Optinose, Inc.
YARDLEY, Pa., Oct. 16, 2024 (GLOBE NEWSWIRE) -- OptiNose, Inc. (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AMMO, Inc.
October 16, 2024 11:45 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In AMMO To Contact Him Directly To Discuss Their Options If you...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Super Micro Computer
October 16, 2024 11:38 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Super Micro Computer To Contact Him Directly To Discuss Their...
James (Josh) Wilson Faruqi & Faruqi, LLP
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bumble Inc.
October 16, 2024 11:37 ET | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Bumble To Contact Him Directly To Discuss Their Options If you...